60mg 3ml tirzepatide / Niacinamide Injection Tirzepatide 60mg Lyophilized (Powdered) -

NCT03819153) was a multicenter, double-blind, randomized (stratified according to the use of sodium-glucose cotransporter 2 [SGLT2] inhibitors at baseline), placebo-controlled clinical trial led by an academic steering committee and conducted at 387 international sites, with a median follow-up of 3.4 (interquartile range 2.94.0) years

In addition, Saxenda added some success stories of patients who had used the injection

The analysis of change in DBP using a fixed-effects model resulted in less of an effect, 1.57 mmHg (95%CI: 1.75 to 1.39) versus 2.45 mmHg for the random effects model

Thinner needles (like 31-32 gauge) reduce injection site pain but may require more pressure to push the medication through, while thicker needles (25-27 gauge) deliver medication faster but can increase discomfort